HEALTH OF WOMAN.2015.4(100):118–121; doi 10.15574/HW.2015.100.118 
 

Клинические аспекты долгосрочной терапии эндометриоза диеногестом 
 

Пирогова В. И., Шурпяк С. А., Кривко Б. Я.

Львовский национальный медицинский университет им. Даниила Галицкого

Коммунальная клиническая больница скорой медицинской помощи, г. Львов 
 

В статье приведены клинические аспекты долгосрочной терапии генитального эндометриоза с применением диеногеста у пациенток с гинекологическим пролиферативным синдромом. 
 

Ключевые слова: генитальный эндометриоз, диеногест, гинекологический пролиферативный синдром. 
 

Литература:

1. ESRHE guideline. http://guidelines. endometriosis. org/pain.html. 2007.

2. Giudice LC. 2010. Endometriosis. N Engl J Med. 362:2389–98. http://dx.doi.org/10.1056/NEJMcp1000274; PMid:20573927 PMCid:PMC3108065

3. Guo SW. 2009. Recurrence of endometriosis and its control. Hum Reprod Updare 15:441–61. http://dx.doi.org/10.1093/humupd/dmp007; PMid:19279046

4. Harada T, Momoeda M, Taketani Y et al. 2009. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter,controlled trial. Fertil Steril. 91(3):675–681. http://dx.doi.org/10.1016/j.fertnstert.2007.12.080; PMid:18653184

5. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P. 2007, Jul 18. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. (3):CD000155.

6. Klipping C, Duijkers I, Faustmann TA et al. 2010. Pharmacodynamic study of four oral dosages of dienogest. Fertil Steril 94 (suppl):S181.

7. Leyland N, Casper R, Laberge Ph, Singh SS et al. 2010. Endometriosis: diagnosis and management. SOGC Clinical and practical guideline. Journal of Obstetrics and Gynaecology Canada 32(7):1–28.

8. Management of endometriosis. Practical Bulletin 114. The American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223–36.

9. McCormack PL. 2010. Dienogest: a review of its use in the treatment of endometriosis. Drugs. 70(16):2073–88. http://dx.doi.org/10.2165/11206320-000000000-00000; PMid:20964453

10. Momoeda M, Harada T, Terakawa N et al. 2009. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res. 35(6):1069–1076. http://dx.doi.org/10.1111/j.1447-0756.2009.01076.x; PMid:20025633

11. Momoeda M, Taketani Y. 2007. Randomized double-blind, multicentre, parallel-group dose–response study of dienogest in patients with endometriosis. Jpn Pharmacol Ther. 35:769–783.

12. Petraglia F, Hornung D, Seitz C et al. 2011. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 285(1): 167–173.

13. Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K et al. 2008. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73:222–231. http://dx.doi.org/10.1016/j.steroids.2007.10.003; PMid:18061638

14. Strowitzki T, Faustmann T, Gerlinger C et al. 2010. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 151:193–198. http://dx.doi.org/10.1016/j.ejogrb.2010.04.002; PMid:20444534

15. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. 2010. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: A 24-week, randomized, multicentre, open-label trial. Hum Reprod. 25(3):633–641. http://dx.doi.org/10.1093/humrep/dep469; PMid:20089522

16. Johnson N et al. 2013. Consensus on current management of endometriosis. Hum. Reprod. 28(6):1552–1568.